Prostate News and Research

RSS

Mayo clinic finds NSAIDs may prevent or delay enlarged prostate

Mayo Clinic researchers have found that taking nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin or ibuprofen may prevent or delay benign prostatic hyperplasia.

30 Aug 2006

Variances in patterns of care for patients with prostate cancer failing primary therapy

Variables that impact management of failed primary therapy for prostate cancer (CaP) are not well defined.

21 Aug 2006

Intermittent androgen deprivation in biochemical recurrence of prostate cancer after radiotherapy

Intermittent androgen deprivation (IAD) is commonly used in the treatment of CaP, which theoretically may delay the development of hormone resistance.

17 Aug 2006

Pomegranate juice may decrease PSA progression in patients with cancer recurrence after treatment

Because of their high content of antioxidants, pomegranate juice is frequently recommended for cancer prevention and overall wellness. While small studies have suggested a role against prostate carcinogenesis, no organized trials have been published until now.

17 Aug 2006

When a patient is diagnosed with prostate cancer, what determines whether he will receive early androgen ablation?

While the benefits of androgen ablation therapy have been well documented in patients with locally advanced and metastatic prostate cancer, there is a paucity of evidence its role in patients with low-grade, low-stage disease.

16 Aug 2006

Watch and wait the best option for low-risk prostate cancer

According to the American Cancer Society, 234,000 men will be diagnosed with prostate cancer this year, and 27,350 will die from it, but researchers say that as many as half of men diagnosed with low-risk prostate cancer undergo surgery or radiation therapy unnecessarily.

15 Aug 2006

Cancer patient receives first proton therapy treatment

A Cocoa Beach man with prostate cancer has become the first patient to undergo treatment at the new University of Florida Proton Therapy Institute, the first time the most advanced form of radiation therapy available has been offered in the Southeast.

15 Aug 2006

The role of transurethral resection of the prostate and biopsy of the peripheral zone after pepeated negative biopsies in the diagnosis of prostate cancer examined

Persistent suspicion of prostate cancer despite repeated negative prostate biopsies is a common problem in urologic practice.

15 Aug 2006

New blood test picks up early breast cancer

A new blood test has been developed by an international team of scientists which can detect the very early stage of breast cancer.

7 Aug 2006

Txr1 gene that affects human cancer cells' sensitivity to chemotherapy

Gene that affects human cancer cells' sensitivity to chemotherapy - an important finding in the effort to increase the effectiveness of chemotherapy.

6 Aug 2006

Turning the immune system against cancer

Medicine can now prevent a host of diseases with a mere shot of vaccine. Polio and smallpox are almost non-existent, and mumps and chicken pox are rarely seen nowadays.

4 Aug 2006

BRIT1 gene plays a pivotal role in DNA damage detection and repair

A single gene plays a pivotal role launching two DNA damage detection and repair pathways in the human genome, suggesting that it functions as a previously unidentified tumor suppressor gene.

3 Aug 2006

Variation in the CHEK2 gene may triple a woman's risk of developing breast cancer

Study shows that women in the general population who carry a specific CHEK2 mutation are three times as likely as women without the mutation to develop breast cancer.

2 Aug 2006

Altering fatty acid levels in diet may reduce prostate cancer growth rate

UCLA researchers found that altering the fatty acid ratio found in the typical Western diet to include more omega-3 fatty acids and decrease the amount of omega-6 fatty acids may reduce prostate cancer tumor growth rates and PSA levels.

2 Aug 2006

Heat sensitivity may make testicular cancer cells more susceptible to standard treatments and die off more readily

Experts at Johns Hopkins have linked scientific evidence spanning more than 30 years to suggest an explanation for why testicular cancer patients like seven-time Tour de France winner Lance Armstrong survive far better than patients with other advanced cancers.

26 Jul 2006

Cancer Research Technology announce collaboration with Hammersmith Hospital to develop high intensity focused ultrasound for the treatment of cancer

Cancer Research Technology (CRT), the oncology-focused development and commercialisation company wholly owned by Cancer Research UK, today announce that they have entered into an agreement with Hammersmith Hospitals NHS Trust (London, UK) to develop Phased Array High-Intensity Focused Ultrasound (HIFU) for the treatment of cancer.

26 Jul 2006

Birch bark compound may be potent prostate cancer fighter

A compound found in the bark of the white birch tree - betulonic acid, a derivative of betulinol - may finally have been rendered a water-soluble, bio-available drug, and is already showing the potential to be a possible agent against prostate cancer - in cell culture and in an animal model.

25 Jul 2006

Prostate News and Research

Mayo clinic finds NSAIDs may prevent or delay enlarged prostate

Variances in patterns of care for patients with prostate cancer failing primary therapy

Intermittent androgen deprivation in biochemical recurrence of prostate cancer after radiotherapy

Pomegranate juice may decrease PSA progression in patients with cancer recurrence after treatment

When a patient is diagnosed with prostate cancer, what determines whether he will receive early androgen ablation?

Watch and wait the best option for low-risk prostate cancer

Cancer patient receives first proton therapy treatment

The role of transurethral resection of the prostate and biopsy of the peripheral zone after pepeated negative biopsies in the diagnosis of prostate cancer examined

New blood test picks up early breast cancer

Txr1 gene that affects human cancer cells' sensitivity to chemotherapy

Turning the immune system against cancer

BRIT1 gene plays a pivotal role in DNA damage detection and repair

Variation in the CHEK2 gene may triple a woman's risk of developing breast cancer

Altering fatty acid levels in diet may reduce prostate cancer growth rate

Heat sensitivity may make testicular cancer cells more susceptible to standard treatments and die off more readily

Cancer Research Technology announce collaboration with Hammersmith Hospital to develop high intensity focused ultrasound for the treatment of cancer

Birch bark compound may be potent prostate cancer fighter

Biomira Stimuvax prostate cancer study results published

New diagnostic tool for prostate cancer

New hope for women with Alzheimer's disease

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News